IDH2 p.R172K

Biomarker type: Somatic variant

Gene context: IDH2

HGVS.p: NP_002159.2:p.Arg172Lys

Precision oncology relationships for therapeutic response involving this biomarker.

Organizations	Biomarkers	Cancer types	Therapies
FDA (1)	IDH2 p.R172K	Acute Myeloid Leukemia	Enasidenib
FDA (1) HC (1)	IDH2 p.R172K	Astrocytoma	Vorasidenib
FDA (1) HC (1)	IDH2 p.R172K	Oligodendroglioma	Vorasidenib